Navidea Biopharmaceuticals, Inc.
(NYSE Amex Equities : NAVB)

( )
NAVB After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 0.48%53.970.9%$1408.01m
JNJJohnson & Johnson -0.05%179.540.7%$1296.44m
BMYBristol-Myers Squibb Co. 0.45%77.591.0%$1212.16m
MRKMerck & Co., Inc. -1.53%92.320.7%$1167.02m
ABBVAbbVie, Inc. -0.92%150.561.9%$1100.30m
LLYEli Lilly & Co. 2.11%313.481.1%$967.28m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -0.29%142.980.0%$491.89m
AZNAstraZeneca Plc -0.17%66.701.0%$491.50m
NVSNovartis AG 0.01%91.260.2%$259.85m
GSKGlaxoSmithKline Plc -1.23%44.420.2%$257.59m
VERUVeru, Inc. 2.18%12.640.0%$253.71m
HZNPHorizon Therapeutics Plc 2.45%90.595.4%$196.03m
SGENSeagen Inc. 1.46%138.465.7%$185.67m
NVONovo Nordisk A/S 1.30%106.620.1%$182.89m
VTRSViatris, Inc. 1.44%12.010.0%$165.27m

Company Profile

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.